Page 189 - Read Online

Page 6 of 8 Vakhtangadze et al. Vessel Plus 2019;3:19 I http://dx.doi.org/10.20517/2574-1209.2019.07

hypertension, preeclampsia/eclampsia are gender-specific risk-factors for further cardiovascular morbidity
in women, which is possible to reveal in young ages and start prevention as early as possible. Seems
abnormalities detected during pregnancy are linked to life-long cardiovascular morbidity, so pregnancy-
related morbidity starts to exceed concerns of obstetricians and takes the important part of primary care
physicians and cardiologists as well. Is pregnancy just revealing or predisposing factor of development
cardiovascular diseases is not still clear and to answer these questions more and more studies are required.

DECLARATIONS
Authors’ contributions
Study design: Vakhtangadze T
Data collection: Gakhokidze N
Manuscript writing: Vakhtangadze T, Gakhokidze N
Manuscript review: Vakhtangadze T
Serching and evaluating the references: Khutsishvili M, Mosidze S

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2019.

REFERENCES
1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, et al. Heart disease and stroke statistics-2015 update: a report from the
American Heart Association. Circulation 2015;131:e29-322.
2. Khan K, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet
2006;367:1066-74.
3. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, et al. Effectiveness based guidelines for the prevention of cardiovascular
disease in women-2011 update: a guideline from the American Heart Association. Circulation 2011;123:1243-62.
4. Shalimova A. Heart and vascular remodeling in essential hypertension and type 2 diabetes is dependent on genetic polymorphisms.
Vessel Plus 2017;1:84-90.
5. Bilovol O. Predictors of hormonal and metabolic disorders of arterial hypertension and type 2 diabetes mellitus comorbidity. Vessel Plus
2017;1:22-8.
6. Roberts JM, August PA, Bakris G, Barton JR, Bernstein IM, et al. Hypertension in pregnancy: report of the American college of
obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol 2013;122:1122-31.
7. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;33:130-7.
8. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension.
Journal of Hypertension 2013;31:1281-357.
9. Gifford RW, August PA, Cunningham G, Green LA, Lindheimer MD, et al. Report of the national high blood pressure education
program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S1-22.
10. ACOG technical bulletin. Hypertension in pregnancy. Number 219--January 1996 (replaces no. 91, February 1986). Committee on
Technical Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1996;53:175-83.